pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
996
stories
Sep 6, 26
AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies
fiercebiotech
Sep 6, 26
Made Fresh Salads, Inc. Recalls Ready to Eat Deli Style Salads and Cream Cheese Because of Possible Health Risk
fda recalls
Sep 5, 26
CAR-T deaths prompt halt by Novartis; Eli Lilly’s 13th acquisition of 2026; and more
endpoints
Sep 4, 26
Trailing rivals, AbbVie scores win with dual-acting myeloma drug
biopharma dive
Sep 4, 26
This week in charts: China deals, stock flatlines and Lilly’s M&A spree
biopharma dive
Sep 4, 26
Foods Alive Recalls Organic Moringa Leaf Powder Because of Possible Health Risk
fda recalls
Sep 4, 26
STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more
stat
Sep 4, 26
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
biopharma dive
Sep 4, 26
AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study
biospace
Sep 4, 26
Opinion: Make infectious disease data boring again
stat
Sep 3, 26
TScan cuts 75% of workforce while shifting focus to solid tumor program
biospace
Sep 3, 26
The hidden scale-out problem behind CAR-T’s growth
biopharma dive
Sep 3, 26
AbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trial
fiercebiotech
Sep 3, 26
The pediatricians who take in vaccine-skeptical parents others won’t
stat
Sep 3, 26
Biopharma needs more data scientists. Who's getting hired?
biospace
Sep 3, 26
B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter
fda medwatch
Sep 2, 26
Novartis CAR-T deaths raise questions over acceptable autoimmune risk
endpoints
Sep 2, 26
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
biopharma dive
Sep 2, 26
Frutas y Hortalizas Del Sur S.A. Expands Recall to Include One Lot of Great Value Frozen Organic Triple Berry Blend Because of Potential Contamination with Escherichia Coli 0145 (E. Coli O145)
fda recalls
Sep 2, 26
Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute
biopharma dive
Sep 2, 26
HHS spins a tale of a would-be content creator child
stat
Sep 2, 26
Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing
biospace
Sep 2, 26
Teva autoimmune antibody notches ph. 2 win in celiac disease
fiercebiotech
Sep 2, 26
TScan axes 75% of workforce to make room for solid tumor programs
fiercebiotech
Sep 2, 26
Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals
biospace
Sep 1, 26
STAT+: House votes to temporarily block Trump plan to politicize federal grants
stat
Sep 1, 26
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
fiercebiotech
Sep 1, 26
Novartis says MS pill succeeds in two large studies
biopharma dive
Sep 1, 26
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
biospace
Sep 1, 26
Alumis’ TYK2 drug fails in key lupus study
biopharma dive
← prev
page 17 of 34
next →